End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
45,850 ARS | +1.61% |
|
+3.03% | +75.78% |
Jul. 10 | Citigroup Adjusts Price Target on Colgate-Palmolive to $112 From $103 | MT |
Jul. 10 | Wells Fargo Adjusts Price Target on Colgate-Palmolive to $97 From $92 | MT |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The company returns high margins, thereby supporting business profitability.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Analyst opinion has improved significantly over the past four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- With an expected P/E ratio at 27.73 and 25.18 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company's enterprise value to sales, at 4.32 times its current sales, is high.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
Ratings chart - Surperformance
Sector: Personal Products
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+75.78% | 79.9B | - | ||
+12.97% | 394B | C- | ||
+15.95% | 141B | B- | ||
-2.00% | 73.46B | A- | ||
-30.52% | 36.65B | B+ | ||
-16.77% | 33.89B | - | ||
+1.44% | 33.53B | B- | ||
+11.92% | 18.53B | A- | ||
+27.38% | 17.69B | B | ||
+12.95% | 13.41B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- CL Stock
- CL Stock
- Ratings Colgate-Palmolive Company